Table 4. Patients subjected to xenograft: clinical and pathological features.
| Pt number | Age | (p)TNM | SBR grade | Vascular invasion | Biopsy site | Subtype | Disease sites | disease-free interval (months) | Prior chemoth. | Engraftment (days) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 57 | pT2N0M0 | 3 | POS | LUNG | TN | BRAIN, NODE, LUNG, LIVER | 26 | 4 | YES (82) |
| 3 | 65 | T4dN2M0 | 3 | UK | SKIN | HER2+ | SKIN | 13 | 2 | YES (182) |
| 4 | 73 | pT1N0M1 | 2 | NEG | PERITONEUM | HER2+ | BONE, PERITONEUM, UTERUS, NODE | 103 | 6 | NO |
| 6 | 49 | T3N1M1 | 3 | UK | BREAST | TN | SKIN, BREAST | NA | 5 | YES (132) |
| 7 | 45 | pT2N1M0 | 3 | POS | LIVER | TN | LIVER, NODE, BONE | 14 | 1 | YES (50) |
| 8 | 58 | pTxNxM0 | UK | UK | PERITONEUM | HER2+ | PERITONEUM | 51 | 1 | NO |
| 9 | 48 | T1N1M1 | UK | UK | LIVER | TN | LIVER, BONE | NA | 2 | NO |
| 10 | 41 | pT2N1bM0 | 3 | POS | LIVER | RH+/HER2- | LIVER, BONE | 14 | 9 | YES (419) |
| 11 | 69 | pT1N0M0 | 2 | UK | LIVER | HER2+ | LIVER | 85 | 8 | YES (329) |
| 12 | 51 | T4dN2M0 | 3 | NA | SKIN | TN | SKIN, NODES, LUNG, PLEURA | 17 | 2 | NO |
| 13 | 68 | pT1N1M0 | 2 | POS | BREAST | RH+/HER2- | BONE, NODE LIVER, BREAST | 171 | 1 | YES (259) |
| 14 | 71 | pT2N2M0 | UK | UK | PERITONEUM | RH+/HER2- | BONE, PERITONEUM | 134 | 2 | NO |
| 16 | 54 | pT2N0M0 | 3 | NEG | LIVER | RH+/HER2- | LIVER, BONE NODE | 95 | 6 | NO |
| 17 | 56 | pTxNxM0 | UK | UK | PERITONEUM | RH+/HER2- | PERITONEUM, LIVER | 100 | 4 | NO |
| 18 | 42 | TxNxM0 | UK | UK | SKIN | TN | SKIN, NODES PANCREAS | 20 | 3 | YES (116) |
| 19 | 54 | TxN1M0 | UK | UK | SKIN | HER2+ | SKIN, NODES | 72 | 4 | NO |
| 20 | 37 | pT1N1M0 | 3 | NEG | LIVER | RH+/HER2- | LIVER, BONE | 24 | 4 | NO |
| 21 | 52 | pT1N0M0 | 3 | POS | LIVER | TN | NODES, LIVER | 23 | 4 | YES (131) |
| 22 | 43 | T0N3M1 | 2 | NEG | LIVER | RH+/HER2- | LUNG, BONE, NODE, LIVER | NA | 2 | NO |
| 25 | 64 | T0N1M1 | 3 | UK | ASCITIS | TN | PERITONEUM, NODES | NA | 3 | YES (51) |
| 26 | 78 | pTxNxM0 | UK | UK | SKIN | RH+/HER2- | SKIN, BONE | 119 | 2 | NO |
* Only patients transplanted and evaluable for engraftment are shown (N=21)